During the past decade, Sankara Nethralaya conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sankara Nethralaya" are "Non Infectious Uveitis" (1 trials), "Ocular Hypertension" (1 trials), "Panuveitis" (1 trials), "Primary Open Angle Glaucoma" (1 trials) and "Uveitis" (1 trials). Many other conditions were trialed in "Sankara Nethralaya" in a lesser frequency.

Most popular intervention types in "Sankara Nethralaya" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (2 trials), "4mg CLS-TA Suprachoriodal Injection" (1 trials), "Azopt®" (1 trials), "Brinzolamide ophthalmic suspension" (1 trials) and "DE-109 Intravitreal Injections" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sankara Nethralaya" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Sankara Nethralaya". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sankara Nethralaya, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sankara Nethralaya, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Sankara Nethralaya has several departments that took part in Clinical trials: "Department of Opthalmology, Sankara Nethralaya, Medical Research Foundation," - 2 trials